Problems with penile erection may seem a simple problem but somehow can make a man’s life miserable. For one, the ill condition can greatly affect a person emotionally due to accumulation of anxiety, depression, and the fear of being rejected. Certain diseases have also been proven to link with impotency, such as heart problems and the loss of sexual libidos. In short, erection problems can deteriorate a man’s overall health – both the psychological and physical aspect. It has the potential to destroy romantic relationships and even worst, can lead to serious psychological problems. Recently, specific drugs have been designed to counteract with erection dysfunction – Vardenafil hcl 20mg, the most recommended medication by physicians to improve sexual performance among men.
Avanafil is the latest erectile dysfunction (ED) treatment medication to enter the ED market. Its brand name, Stendra, is made and manufactured by Vivus Inc. Avanafil is classified as a PDE5 inhibitor drug and competes directly with the likes of Viagra, Levitra, and Cialis. The last ED drug was released in 2003 (with the exception of Staxyn which was released in 2010 but is very similar to Levitra in nature) which is why many are a bit amazed as well as perplexed as to why in 2012, a new ED drug was released in the market that is notably dominated by the big three. However, the confusion was gone when those men with ED braved to test the new ED drug.
For those who were brave enough to buy avanafil and test the new ED drug, they were amazed to find out that the drug was very effective in providing the necessary erection needed for a successful sexual intercourse. Not only did the new drug provide them with a high efficacy, but the drug also had lesser side effects than the more popular ED drug Viagra. Despite being new in the ED market, it simply proved that the new ED medication has what it takes to compete against the big three in ED medications. Continue reading Avanafil – The Latest ED Treatment in the ED Market